| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0003 |
| 1 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 2 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0002 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0001 |
| 5 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 2 | 0.0000 |
| 7 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 9 | Azole Antifungal [EPC] | 3 | 0.0000 |
| 10 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 11 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 12 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 13 | Retinoid [EPC] | 1 | 0.0000 |
| 14 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 15 | Corticosteroid [EPC] | 3 | 0.0000 |
| 16 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |